Healthcare provider profile · identity verified

Lewis Todd Edwards

Allopathic & Osteopathic Physicians|Internal Medicine · MESQUITE, TX · NPI 1871524488

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Lewis Todd Edwards received $67.89 in general payments during 2025 across 3 reported records.

BridgeBio Pharma, Inc. accounted for 41.9% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 41 claims for Symbicort by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 55 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 36 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$67.89

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
BridgeBio Pharma, Inc.	Unresolved — no canonical attribution shown	$28.41	41.9%	1	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$20.87	30.7%	1	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$18.61	27.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$67.89	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Attruby Normalized: attruby	Drug	BridgeBio Pharma, Inc.	$28.41	1	2025
Source payment records 2025-07-10 · BridgeBio Pharma, Inc. · $28.41 · Open Payments source
AMYVID Normalized: amyvid	Drug	Lilly USA, LLC	$20.87	1	2025
Source payment records 2025-08-18 · Lilly USA, LLC · $20.87 · Open Payments source
KISUNLA Normalized: kisunla	Drug	Lilly USA, LLC	$20.87	1	2025
Source payment records 2025-08-18 · Lilly USA, LLC · $20.87 · Open Payments source
FARXIGA Normalized: farxiga	Drug	AstraZeneca Pharmaceuticals LP	$18.61	1	2025
Source payment records 2025-08-19 · AstraZeneca Pharmaceuticals LP · $18.61 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
FARXIGA farxiga	2025	Farxiga	2024	19 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	19	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	41	11
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	55	16
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	36	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1392	429
Amlodipine Besylate	Amlodipine Besylate	1003	305
Levothyroxine Sodium	Levothyroxine Sodium	966	287
Losartan Potassium	Losartan Potassium	674	200
Lisinopril	Lisinopril	532	177
Gabapentin	Gabapentin	515	168
Sertraline Hcl	Sertraline Hcl	461	146
Metoprolol Succinate	Metoprolol Succinate	459	145
Metformin Hcl	Metformin Hcl	401	124
Rosuvastatin Calcium	Rosuvastatin Calcium	400	124
Omeprazole	Omeprazole	392	123
Tamsulosin Hcl	Tamsulosin Hcl	392	119
Pravastatin Sodium	Pravastatin Sodium	382	111
Meloxicam	Meloxicam	378	155
Carvedilol	Carvedilol	340	108
Trazodone Hcl	Trazodone Hcl	340	105
Simvastatin	Simvastatin	331	97
Hydrochlorothiazide	Hydrochlorothiazide	310	99
Pantoprazole Sodium	Pantoprazole Sodium	294	101
Furosemide	Furosemide	280	113
Montelukast Sodium	Montelukast Sodium	277	91
Eliquis	Apixaban	265	73
Allopurinol	Allopurinol	203	61
Potassium Chloride	Potassium Chloride	191	67
Ezetimibe	Ezetimibe	189	63
Alprazolam	Alprazolam	183	44
Glipizide	Glipizide	169	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	162	38
Duloxetine Hcl	Duloxetine Hcl	161	51
Escitalopram Oxalate	Escitalopram Oxalate	160	45
Ibandronate Sodium	Ibandronate Sodium	156	56
Ozempic	Semaglutide	156	39
Albuterol Sulfate Hfa	Albuterol Sulfate	152	61
Metoprolol Tartrate	Metoprolol Tartrate	147	49
Finasteride	Finasteride	143	51
Clopidogrel	Clopidogrel Bisulfate	136	41
Donepezil Hcl	Donepezil Hcl	136	49
Synthroid	Levothyroxine Sodium	132	36
Fluticasone Propionate	Fluticasone Propionate	122	52
Mirtazapine	Mirtazapine	113	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	112	36
Alendronate Sodium	Alendronate Sodium	108	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	105	37
Hydralazine Hcl	Hydralazine Hcl	104	40
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	99	32
Spironolactone	Spironolactone	98	32
Zolpidem Tartrate	Zolpidem Tartrate	98	27
Esomeprazole Magnesium	Esomeprazole Magnesium	96	30
Metformin Hcl Er	Metformin Hcl	93	27
Tramadol Hcl	Tramadol Hcl	93	30
Atenolol	Atenolol	88	25
Valsartan	Valsartan	88	29
Nifedipine Er	Nifedipine	85	27
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	85	72
Xarelto	Rivaroxaban	77	23
Januvia	Sitagliptin Phosphate	72	13
Azithromycin	Azithromycin	70	62
Prednisone	Prednisone	68	47
Famotidine	Famotidine	67	25
Memantine Hcl	Memantine Hcl	62	17
Olmesartan Medoxomil	Olmesartan Medoxomil	61	21
Pregabalin	Pregabalin	61	15
Venlafaxine Hcl Er	Venlafaxine Hcl	61	19
Amoxicillin	Amoxicillin	60	50
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	50
Ropinirole Hcl	Ropinirole Hcl	60	16
Lovastatin	Lovastatin	59	18
Fenofibrate	Fenofibrate Nanocrystallized	58	18
Glipizide Er	Glipizide	57	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	18
Celecoxib	Celecoxib	55	22
Jardiance	Empagliflozin	55	16
Mupirocin	Mupirocin	53	31
Oxybutynin Chloride	Oxybutynin Chloride	53	17
Fluoxetine Hcl	Fluoxetine Hcl	52	17
Torsemide	Torsemide	52	21
Buspirone Hcl	Buspirone Hcl	51	15
Methocarbamol	Methocarbamol	50	27
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	49	15
Breo Ellipta	Fluticasone/Vilanterol	46	suppressed
Estradiol	Estradiol	45	17
Triamcinolone Acetonide	Triamcinolone Acetonide	45	24
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	44	20
Citalopram Hbr	Citalopram Hydrobromide	43	15
Ipratropium Bromide	Ipratropium Bromide	43	18
Terazosin Hcl	Terazosin Hcl	42	11
Warfarin Sodium	Warfarin Sodium	42	12
Symbicort	Budesonide/Formoterol Fumarate	41	11
Azelastine Hcl	Azelastine Hcl	39	18
Bupropion Xl	Bupropion Hcl	39	13
Irbesartan	Irbesartan	38	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	37	12
Glimepiride	Glimepiride	37	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	13
Temazepam	Temazepam	36	suppressed
Trulicity	Dulaglutide	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	12
Myrbetriq	Mirabegron	35	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	35	12
Propranolol Hcl	Propranolol Hcl	35	12
Ventolin Hfa	Albuterol Sulfate	35	16
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Trospium Chloride	Trospium Chloride	34	19
Valacyclovir	Valacyclovir Hcl	33	12
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Clonazepam	Clonazepam	32	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	31	suppressed
Lorazepam	Lorazepam	31	suppressed
Ondansetron Odt	Ondansetron	31	23
Cephalexin	Cephalexin	30	23
Doxycycline Monohydrate	Doxycycline Monohydrate	30	26
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	24
Clonidine Hcl	Clonidine Hcl	29	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	12
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Verapamil Er	Verapamil Hcl	27	suppressed
Colchicine	Colchicine	26	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	26	suppressed
Baclofen	Baclofen	25	12
Nebivolol Hcl	Nebivolol Hcl	25	suppressed
Ramipril	Ramipril	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	14
Dicyclomine Hcl	Dicyclomine Hcl	24	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Linzess	Linaclotide	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Ciclopirox	Ciclopirox	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Gemtesa	Vibegron	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Potassium Citrate Er	Potassium Citrate	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Nitroglycerin	Nitroglycerin	18	14
Novolog Flexpen	Insulin Aspart	18	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	18	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Diazepam	Diazepam	17	suppressed
Felodipine Er	Felodipine	17	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	17	suppressed
Verapamil Sr	Verapamil Hcl	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Lactulose	Lactulose	14	suppressed
Galantamine Er	Galantamine Hbr	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Nystatin	Nystatin	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Naloxone Hcl	Naloxone Hcl	12	12
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Quviviq	Daridorexant Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$67.89 · 3 records	BridgeBio Pharma, Inc.	AMYVID, Attruby, FARXIGA, KISUNLA	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Farxiga play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error